Hemoglobin Level Variability: Associations with Mortality
نویسندگان
چکیده
منابع مشابه
Hemoglobin level variability: associations with mortality.
BACKGROUND/OBJECTIVES Awareness of hemoglobin level variability in dialysis patients is increasing, as is interest in its potential implications. In this retrospective, national study of associations between the degree of hemoglobin level variability in the first 6 mo of 2004 and subsequent mortality rates in the following 6 mo, 159,720 hemodialysis patients receiving epoetin therapy were studi...
متن کاملHemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations.
National payment policies target a hemoglobin range of 11 to 12.5 g/dl for patients with ESRD. However, clinical complications and provider practices may contribute to wide fluctuations over time. This study evaluated the frequency with which patients maintain stable hemoglobin levels below, within, and above the Centers for Medicare & Medicaid Services target range and assessed patterns of hem...
متن کاملHemoglobin level variability: anemia management among variability groups.
BACKGROUND/AIMS Hemoglobin level variability in hemodialysis patients is common, and has been associated with comorbidity, intercurrent illness, and mortality risk. We aimed to describe the influence of anemia management interventions (erythropoiesis-stimulating agents [ESAs], intravenous iron, and transfusions) on hemoglobin variability. METHODS We studied all Medicare primary payer hemodial...
متن کاملHemoglobin variability does not predict mortality in peritoneal dialysis patients.
BACKGROUND Hemoglobin variability in hemodialysis patients treated with erythropoiesis-stimulating agents has been used to evaluate mortality and comorbidity. Different outcomes have been reported in American and European hemodialysis patients. There are, however, few studies of the effects of hemoglobin variability in peritoneal dialysis patients. METHODS We investigated hemoglobin variabili...
متن کاملHemoglobin variability does not predict mortality in European hemodialysis patients.
Patients with CKD exhibit significant within-patient hemoglobin (Hb) level variability, especially with the use of erythropoiesis stimulating agents (ESAs) and iron. Analyses of dialysis cohorts in the United States produced conflicting results regarding the association of Hb variability with patient outcomes. Here, we determined Hb variability in 5037 European hemodialysis (HD) patients treate...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Journal of the American Society of Nephrology
سال: 2007
ISSN: 1555-9041,1555-905X
DOI: 10.2215/cjn.01610407